Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM144 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNF13 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CNP - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ENDOD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SCARB2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RBPJ - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NCAM1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TLE4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MPC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PPP2R3A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RHOB - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MBOAT2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARAP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FGFR2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TIMP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC44A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ELOVL5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LIPA - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SCCPDH - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MAGT1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on